Neo Ivy Capital Management’s Privia Health PRVA Stock Holding History

Neo Ivy Capital Management’s Portfolio PRVA Stock Details PRVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.1K	Buy	+624	New	+$14.5K	﹤0.01%	330
2025 Q3	–	Sell	-67,526	Closed	-$1.55M	–	510
2025 Q2	$1.55M	Buy	+67,526	New	+$1.56M	0.5%	71
2025 Q1	–	Sell	-6,540	Closed	-$127K	–	399
2024 Q4	$127K	Buy	6,540 +2,936	+81%	+$58.2K	0.03%	229
2024 Q3	$66K	Buy	+3,604	New	+$68.8K	0.02%	242
2023 Q4	$9K	Buy	+372	New	+$8.33K	0.02%	239
2023 Q3	–	Sell	-2,040	Closed	-$53K	–	431
2023 Q2	$53K	Buy	+2,040	New	+$53.9K	0.03%	250
2022 Q4	$508K	Buy	22,356 +21,743	+3,547%	+$605K	0.34%	120
2022 Q3	$21K	Buy	+613	New	+$22.7K	0.06%	292
2022 Q2	–	Sell	-7,346	Closed	-$196K	–	574
2022 Q1	$196K	Buy	+7,346	New	+$173K	0.18%	202

Other funds holding PRVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Neo Ivy Capital Management's PRVA Position: Q2 2026 in Review

Neo Ivy Capital Management opened a new position in Privia Health (PRVA) in Q2 2026: 624 shares worth $16.1K. The stake represents ﹤0.01% of the portfolio and ranks #330 among its holdings. This is a return to the name: Neo Ivy Capital Management previously reported a position in PRVA as recently as Q2 2025.

Neo Ivy Capital Management first reported a position in PRVA in Q1 2022 and has held it in 9 quarters since. The position peaked at $1.55M in Q2 2025. 302 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

Neo Ivy Capital Management held 624 shares of Privia Health worth $16.1K as of Q2 2026.
Privia Health was a new Neo Ivy Capital Management position in Q2 2026.
Privia Health made up ﹤0.01% of Neo Ivy Capital Management's portfolio in Q2 2026, its #330 holding.
Neo Ivy Capital Management first reported a position in Privia Health in Q1 2022 and has held it in 9 quarters since.
Neo Ivy Capital Management's Privia Health position peaked at $1.55M in Q2 2025.
302 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Neo Ivy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.